HK OTC rules add to cross-border concerns

The Securities and Futures Commission and Hong Kong Monetary Authority released a joint consultation on their plans to overhaul OTC derivatives regulation in October. But how will the rules fit with the patchwork of legislation drawn up elsewhere? And will they meet the end-2012 deadline set by the G-20 for central clearing?


Hong Kong’s regulators have their hands full over the next 12 months. Having closed a consultation on the proposed regulatory regime for over-the-counter derivatives on November 30, the Hong Kong Monetary Authority (HKMA) and Securities and Futures Commission (SFC) must now work their way through the various responses, come up with primary enabling legislation, consult on the detail of the rules, draw up exhaustive subsidiary legislation, and then implement the new regime. While not a member of

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options

Most read articles loading...

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here